Health Care Reform Means New Disclosure Rules

Law360, New York (April 6, 2010, 8:08 PM EDT) -- Last week, President Barack Obama signed H.R. 3590, the Patient Protection and Affordable Care Act. Among its many provisions is one that, in time, is sure to draw the attention and resources of drug and device manufacturers: a provision requiring that industry payments to doctors be publicly disclosed.

In recent years, a handful of states have enacted laws requiring that drug (and in some states, device) manufacturers aggregate and disclose the amount they spend in those states on the advertising and marketing of drugs and devices,...
To view the full article, register now.